PHAXIAM Therapeutics SA
2.1450
14-June-24 08:45:37
15 minutes delayed
Stocks
-0.3700
-14.71%
Today's range
2.1450 - 2.1600
ISIN
FR001400K4B1
Source
Cboe
-
07 Jun 2024 11:45:00 By Nasdaq GlobeNewswire
-
05 Jun 2024 12:00:00 By Nasdaq GlobeNewswire
-
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
15 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
03 May 2024 12:05:00 By Nasdaq GlobeNewswire
-
15 Apr 2024 01:30:00 By Nasdaq GlobeNewswire
-
09 Apr 2024 12:00:00 By Nasdaq GlobeNewswire
-
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
05 Apr 2024 12:00:00 By Nasdaq GlobeNewswire
-
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update
20 Mar 2024 13:00:00 By Nasdaq GlobeNewswire
-
11 Mar 2024 02:00:00 By Nasdaq GlobeNewswire
-
05 Mar 2024 12:00:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
06 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
18 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
06 Dec 2023 16:05:00 By Nasdaq GlobeNewswire
-
PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
14 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
-
07 Nov 2023 12:00:00 By Nasdaq GlobeNewswire
-
24 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendation
23 Oct 2023 16:05:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 12:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >